AstroNova, Inc. (Nasdaq: ALOT) agreed on June 17, 2026 to be acquired by Nashville-based private equity firm Arcline Investment Management at $29.00 per share in an all-cash transaction, valuing the company at approximately $272 million, according to BusinessWire and The Middle Market.

The all-cash structure is worth noting. Instead of paying partly in Arcline stock, the firm is writing a check for the full amount. For a company of AstroNova's size — roughly $272 million in total value — this approach eliminates a key risk: shareholders don't have to gamble on whether Arcline's own stock price stays stable between now and closing. They lock in their price today and get paid in full when the deal ends.

Arcline specializes in industrial technology companies — the kind of specialized manufacturers that make hardware and embedded software for niche industrial markets. AstroNova fits that profile squarely. The firm invests in businesses with strong competitive advantages rooted in technical expertise, the kind of advantage that's hard for competitors to replicate. Arcline's strategy centers on taking patient ownership stakes in these companies, letting them invest in product development and sales channels without the pressure of hitting quarterly earnings targets that public markets demand.

The $272 million valuation places this deal in the lower-middle market segment — Arcline's home turf. Industrial technology companies like AstroNova, which makes specialized test and measurement equipment and ruggedized printing systems for aerospace and defense applications, typically sell at valuations that reflect both customer stickiness and the high cost of maintaining certifications in regulated industries.

Take-privates at this size and structure have become routine in private equity. The reason is structural: public market liquidity has dried up for companies below roughly $300 million in market cap. The costs of staying listed — compliance work, management distraction, limited analyst attention — have grown harder to justify. A private owner with deep sector knowledge and patient capital can eliminate those friction costs while keeping the door open for add-on acquisitions that would draw unwanted scrutiny as a public company.

Until shareholders approve the deal and regulators clear it, ALOT shares will continue trading in the market. They will likely hover close to the $29.00 offer price but trade at a small discount, reflecting the residual risk that something could derail the deal and the fact that shareholders have to wait for their money.